Foresite Capital Fund VI LP 13D/13G Filings for RAPT Therapeutics, Inc. (RAPT)

Foresite Capital Fund VI LP 13D and 13G filings for RAPT Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-12-30
3:32 pm
Purchase
2024-12-2313GRAPT Therapeutics, Inc.
RAPT
Foresite Capital Fund VI LP1,562,500
9.300%
1,562,500increase
(New Position)
Filing